Clinical Research Directory
Browse clinical research sites, groups, and studies.
Feasibility of a Digital Therapeutic for Adults With Posttraumatic Stress Disorder (PTSD)
Sponsor: Oui Therapeutics, Inc.
Summary
This study is exploring the efficacy of a digital therapeutic app in reducing symptoms of posttraumatic stress disorder (PTSD) in adults.
Official title: Dosage, Feasibility, Acceptability and Usability of OTX-601
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-06-30
Completion Date
2025-11-21
Last Updated
2026-07-27
Healthy Volunteers
No
Conditions
Interventions
OTX-601 Digital Therapeutic - Version 1
Prescription digital therapeutic designed to overcome existing barriers and deliver evidence-based treatment for PTSD
OTX-601 Digital Therapeutic - Version 2
Prescription digital therapeutic (increased dose) designed to overcome existing barriers and deliver evidence-based treatment for PTSD
Treatment as Usual (TAU)
Treatment as usual may include psychotherapy and/or pharmacological interventions.
Locations (1)
Florida State University
Tallahassee, Florida, United States